Previous 10 |
home / stock / iqaif / iqaif news
Imaging Biometrics, a subsidiary of IQ-AI Limited (OTCQB:IQAIF) (LSE:IQAI), discusses its most successful year on record. Increases technology platform and expects record revenues Rolls out Phase I clinical trial and prepares to file 510(K) with the FDA MILWAUKEE, WI / ACCESS...
IB Zero G™ Technology May Benefit Imaging in Pediatric Patients MILWAUKEE, WI / ACCESSWIRE / November 11, 2021 / IQ-AI Limited (OTCQB:IQAIF) (LSE:IQAI) , a developer of medical image processing platforms that have led to effective therapeutic strategies for brain tumor and other p...
Installation Includes IB Neuro™ and IB DCE™ Software Purchase also Includes IB Clinic - Mac Edition MILWAUKEE, WI / ACCESSWIRE / November 2, 2021 / IQ-AI Limited (LSE:IQAI)(OTCQB:IQAIF) , a developer and manufacturer of medical image processing platforms that have led t...
Company Enjoys Most Successful Year on Record Marked Increase in Revenue and Growing Technology Portfolio Sponsorship of a Phase I Clinical Trial MILWAUKEE, WI / ACCESSWIRE / October 28, 2021 / IQ-AI Limited (OTCQB:IQAIF) (LSE:IQAI) , a developer and manufacturer of medical ima...
News, Short Squeeze, Breakout and More Instantly...
(NewsDirect) Dr Jennifer Connelly, MD, the Principal Investigator (PI) of the IQ-AI Limited sponsored phase one clinical trial that is being conducted at the Medical College of Wisconsin, joined Proactive's Stephen Gunnion with a positive update from its treatment for recurring glioblasto...
--News Direct-- Dr Jennifer Connelly, the Principal Investigator (PI) of the IQ-AI Limited sponsored Phase I Clinical Trial that is being conducted at the Medical College of Wisconsin, joins Proactive's Natalie Stoberman to discuss the latest updates from its treatment for recurring gliob...
MILWAUKEE, WI / ACCESSWIRE / July 13, 2023 / Imaging Biometrics, LLC (IB) , a wholly-owned subsidiary of IQ-AI Ltd (LSE:IQAI)(OTCQB:IQAIF) , today announced the U.S. Food and Drug Administration (US FDA) has granted Orphan Drug Designation (ODD) for gallium maltolate (GaM) for the treatment of p...